SCHEMBL6210380

SCHEMBL6210380

CC(C)NC(=O)OSc1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
DYRK1A Q13627 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GRM1 Q13255 1/20 0.39
KDM5A P29375 1/20 0.39
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TP53 P04637 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208526 0.86 HPGD (0.40) ALDH1A1RAB9APOLBL3MBTL1HTT
SCHEMBL27699463 0.79 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2NPC1RAB9AGAA
SCHEMBL6211802 0.78 IDO1 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AGAA
SCHEMBL28198363 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NPC1RAB9AGAA
SCHEMBL27390409 0.75 KMT2A (0.50) ALDH1A1DYRK1AGAAHTTMEN1
SCHEMBL6208983 0.74 HTT (0.53) SMN1; SMN2GAAHTTCYP1A2CYP3A4
SCHEMBL1106964 0.72 HDAC1 (0.62) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL27699462 0.70 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9AGAA
SCHEMBL10014700 0.69 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL13041722 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608662-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-12-28 EP claimed
WO-2004083218-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-09-30 WO claimed
EP-1608662-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-12-28 EP disclosed
WO-2004083218-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-09-30 WO disclosed